A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 249
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TRL
Long Form : triglyceride-rich lipoproteins
No. Year Title Co-occurring Abbreviation
2019 Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State. ANGPTL3, LDL, LOF, VLDL
2019 Moving Targets: Recent Advances in Lipid-Lowering Therapies LDL-C
2019 Novel lipoprotein density profiling in laminitic, obese, and healthy horses. CLPDP, HDLs, LDLs
2019 Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker. apo, apoA-I, BCAA, HDL-C, LDL-C, NMR, PA, TG
2018 Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet. AnxA6, HDL, HFD, KO, WT
2018 Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism. apo
2018 Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis. ANGPTL4, AT, BAT, FA, LPL
2018 Differential associations between plasma concentrations of insulin and glucose and intestinal expression of key genes involved in chylomicron metabolism. apo, IR
2018 Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal Women. apo, FCR, IDL, LDL, PR
10  2018 Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism. CVD, GPIHBP1, LPL
11  2018 New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk? ANGPTL3, apoC-III, CVD, FH
12  2018 Production of asymmetric oxidative metabolites of [13C]-beta-carotene during digestion in the gastrointestinal lumen of healthy men. ---
13  2018 The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins. ICD, LDL, LRP1, PID1
14  2017 A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels. A43T, CHD, LDL-C, TG
15  2017 ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans. hyperTG, IR, WAT
16  2017 ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen. ApoCIII, CHD, LPL, TG
17  2017 Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. apoC-II, CM, HDL, HTG, LPL, TG, VLDL
18  2017 Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men. ---
19  2017 Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects. apoC-III, HDL-C, TGs
20  2017 Indispensable role of lipoprotein bound-ApoE in adipogenesis and endocytosis induced by postprandial TRL. APOE, h-TRL, RAP
21  2016 Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndrome. MetS
22  2016 Deregulated Lipid Sensing by Intestinal CD36 in Diet-Induced Hyperinsulinemic Obese Mouse Model. HFD, MetS, TG
23  2016 Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men. GIP, GLP, OGTT, TG
24  2016 New Therapeutic Approaches to the Treatment of Dyslipidemia. ASCVD, HDL, LDL
25  2016 Remnant lipoprotein size distribution profiling via dynamic light scattering analysis. CVD, RLP
26  2016 Role of sulfatase 2 in lipoprotein metabolism and angiogenesis. HSPG, SULF2
27  2016 Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III. apo, FCR, PR, VLDL
28  2016 [Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update]. CETP, HDL-C, LDL-C, PCSK9
29  2015 Dysfunction of lipid metabolism in lipodystrophic Seipin-deficient mice. CGL, VLDL
30  2015 Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update. CVD, LDL, PUFA, VLDL
31  2015 Effects of egg consumption on carotenoid absorption from co-consumed, raw vegetables. AUCs, HE, LE
32  2015 Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. ESRD, HDL, IDL
33  2015 Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins. HDL, HPLC, IDL, TGOOH, VLDL
34  2015 Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state. apo, AUC, CV, FCRs, HOMA, LPL, PCSK9
35  2015 Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia. apoB, FCR, FHBL, IDL, LDL, VLDL
36  2015 Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. ---
37  2015 Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals inHungary. ---
38  2015 PCSK9 and triglyceride-rich lipoprotein metabolism. LDL, LDLR, PCSK9, TG
39  2014 Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men. apo, MCT, VLDL
40  2014 Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial. LCn3s, VLDLs
41  2014 Effect of sitagliptin therapy on triglyceride-rich lipoprotein kinetics in patients with type 2 diabetes. apo
42  2014 Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans. ---
43  2014 Glucagon-like peptide-2 regulates release of chylomicrons from the intestine. GLP-2
44  2014 Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins. apo, DNL
45  2014 Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. CV, FFA, HDL, LDL, MS, T2DM, TG, VLDL
46  2014 New and emerging regulators of intestinal lipoprotein secretion. FFA
47  2014 Postprandial enrichment of triacylglycerol-rich lipoproteins with omega-3 fatty acids: lack of an interaction with apolipoprotein E genotype? apo, DHA, EPA, FA
48  2014 Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: key players in intestinal physiology and metabolic disorders. LDs
49  2013 Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. HSPG, SDC1
50  2013 Comparison of high-performance liquid chromatography/tandem mass spectrometry and high-performance liquid chromatography/photo-diode array detection for the quantitation of carotenoids, retinyl esters, alpha-tocopherol and phylloquinone in chylomicron-rich fractions of human plasma. APCI, HPLC-PDA
51  2013 Demystifying the management of hypertriglyceridaemia. apo, CVD
52  2013 Dietary fatty acids and lipoprotein metabolism: new insights and updates. CVD, PUFA
53  2013 Exercise prevents fructose-induced hypertriglyceridemia in healthy young subjects. apo
54  2013 Lipids and HCV. apoB, APOE, HCV, LDL, LVP, VLDL
55  2013 Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue. WAT
56  2013 Postprandial lipoproteins and the molecular regulation of vascular homeostasis. ---
57  2013 Postprandial triglyceridemia after single dose of alcohol in healthy young men. HTGL, IDL, LPL, TG
58  2013 The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/macrophage cells. ApoB48R, MUFA, ROO, SFA
59  2013 Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice. BSCL, MEFs
60  2012 Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat. apoB-48, FFA, FGF21, TG, VLDL1
61  2012 Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism. CETP, PR, PS
62  2012 Effects of rs7903146 variation in the Tcf7l2 gene in the lipid metabolism of three different populations. MetS, SNP, TG
63  2012 Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. TLC
64  2012 Low density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of apolipoprotein E. APOE, HDL, LDL, LRP1
65  2012 Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography. FFA, MS
66  2012 Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels. APOE, CTRL, LPL, NS
67  2012 White adipose tissue apolipoprotein C-I secretion in relation to delayed plasma clearance of dietary fat in humans. apo, WAT
68  2011 Acute hypertriglyceridemia promotes intestinal lymphatic lipid and drug transport: a positive feedback mechanism in lipid and drug absorption. CM, MetS
69  2011 Consumption of diets with different type of fat influences triacylglycerols-rich lipoproteins particle number and size during the postprandial state. CHO, MUFA, PUFA, SFA, TG
70  2011 Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters. CETP, HDL, RCT
71  2011 Gut-liver interaction in triglyceride-rich lipoprotein metabolism. ---
72  2011 Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry. HCV, LPL, VLDL
73  2011 Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometry study. ---
74  2011 Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins. FFAs, TG
75  2010 Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins. CVD, HDL-C, LDL-C, TG
76  2010 Cell-mediated lipoprotein transport: a novel anti-atherogenic concept. CR1
77  2010 Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men. HOMA-IR, RLP-C, TG
78  2010 Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. HCV
79  2010 Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk. apoB, SFA
80  2010 The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. ApoB-48, DPP-4, GLP-1
81  2010 Vitamin A equivalence of the ss-carotene in ss-carotene-biofortified maize porridge consumed by women. ---
82  2009 Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia. apo, FCR, PR, PS
83  2009 Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. apoB, HCV, LVP
84  2009 Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. PPM, TG
85  2009 The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients. AUCs
86  2008 Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. apo, FFA
87  2008 Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction. LPL, MI
88  2008 Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III. apo, IDL, MUFA
89  2008 Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production. RSG, TG
90  2008 Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. apo, HMW, LDL, MetS, RBP4, RLP, VLDL
91  2008 Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction. AUC, HDL, LPL, MI, TGR
92  2008 Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery. CASMC, MIC-1, ROO, SMC, VEFO
93  2008 Metabolism and cell biology of vitamin K. LDL, SXR
94  2008 Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test. AUC, PPLT
95  2008 The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men. apo, AUC, RP, TG
96  2008 Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans. FCR, IH, PR
97  2007 Adverse effects of conjugated alpha-linolenic acids (CLnA) on lipoprotein profile on experimental atherosclerosis in hamsters. CLAs, CLnA, CLnAs, HC, HDL-C, LDL, RA, TGs
98  2007 Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma. CETP, DeltaRLP-C, LCAT, RLP, RLP-C, TG
99  2007 Development of a homogeneous assay to measure remnant lipoprotein cholesterol. apo, CHER, CMRs, IDLs, POE-POB, VLDLR
100  2007 Development of a novel method to determine very low density lipoprotein kinetics. TG